comparemela.com

Latest Breaking News On - Pharnext - Page 14 : comparemela.com

Pharnext Announces On-Schedule Completion of Patient Enrollment in its Pivotal Phase III Trial of PXT3003, the PREMIER Trial, for the Treatment of Charcot-Marie-Tooth Disease Type 1A

30.05.2022 - PARIS, FRANCE / ACCESSWIRE / May 30 2022 / Pharnext SA (FR0011191287 - ALPHA) (the Company ), an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases with high unmet medical need, today . Seite 1

France generalNeuropathy limitations scaleDavid horn solomonChief executive officerPivotal phaseBurkhard blankChief medical officer

Pharnext: Pharnext Reports Full Year 2021 Financial Results and Recent Business Updates

DJ Pharnext: Pharnext Reports Full Year 2021 Financial Results and Recent Business Updates Pharnext Pharnext: Pharnext Reports Full Year 2021 Financial Results and Recent Business Updates 25-Apr-2022

France generalJoshua shaferAbhijit panguRaj thotaXavier paoliResearch tax creditClinical developmentHead of regulatory affairsSenior leadership team evolutionPharnext reports full yearRecent business updatesFrench regulatory newsReports full yearCharcot marie tooth disease typeOverall neuropathy limitations scaleOrphanet journal

Pharnext: Pharnext Reports Full Year 2021 -2-

DJ Pharnext: Pharnext Reports Full Year 2021 Financial Results and Recent Business Updates Pharnext Pharnext: Pharnext Reports Full Year 2021 Financial Results and Recent Business Updates 25-Apr-2022

United statesFrance generalJoshua shaferAbhijit panguAlexandra harrisonXavier paoliRaj thotaInternational rare disease dayResearch tax creditEuronext growth stock exchangeHead of regulatory affairsSenior leadership team evolutionClinical developmentPharnext reports full yearRecent business updatesFrench regulatory news

Joshua Schafer Appointed as Interim Chairman of Pharnext Board of Directors

DJ Joshua Schafer Appointed as Interim Chairman of Pharnext Board of Directors Pharnext Joshua Schafer Appointed as Interim Chairman of Pharnext Board of Directors 30-March-2022 / 18:00 CET/CEST Dissemination

United statesFrance generalElisabeth svanbergPharnext joshua schaferAlexandra harrisonJoshua schaferMallinckrodt pharmaceuticalsAstellas pharmaceuticalsEuronext growth stock exchangeTakeda pharmaceuticalsUniversity of notre dameNorthwestern universityShuttle pharmaceuticalsSchafer appointedInterim chairmanPharnext board

Investegate |Pharnext Announcements | Pharnext: Joshua Schafer Appointed as Interim Chairman of Pharnext Board of Directors

Investegate announcements from Pharnext, Joshua Schafer Appointed as Interim Chairman of Pharnext Board of Directors

United statesFrance generalElisabeth svanbergMary jane elliottAlexandra harrisonSukaina virjiJoshua schaferGhislaine gasparettoMallinckrodt pharmaceuticalsAstellas pharmaceuticalsEuronext growth stock exchangeTakeda pharmaceuticalsUniversity of notre dameNorthwestern universityMedia relations internationalConsilium strategic communications

vimarsana © 2020. All Rights Reserved.